BRENTWOOD, Tenn., Oct. 19, 2017 -- Diversicare Healthcare Services, Inc. (NASDAQ:DVCR) today announced that it is scheduled to report financial results for its third quarter ended September 30, 2017, on Thursday, November 2, 2017, after the market closes. Diversicare will also hold a conference call at 5:00 p.m. ET, 4:00 p.m. CT, on Thursday, November 2, 2017.
To participate in the Company's conference call, dial 877-340-2552 (domestic) or 253-237-1159 (International), Conference ID 8697409 and an Operator will connect you to the call. A live broadcast of the conference call will also be available on the Internet at the Company's web site: www.DVCR.com.
A replay of the conference call will be accessible two hours after its completion through November 9, 2017, by dialing 855-859-2056 (domestic) or 404-537-3406 (international) and entering Conference ID 8697409.
Diversicare provides post-acute care services to skilled nursing center patients and residents in ten states, primarily in the Southeast, Midwest and Southwest United States. As of the date of this release, Diversicare operated 76 skilled nursing and long-term care facilities containing 8,457 skilled nursing beds. For additional information about the Company, visit Diversicare's web site: www.DVCR.com.
| Company Contact: | Investor Relations: | ||
| Kelly J. Gill | James R. McKnight, Jr. | ||
| Chief Executive Officer | Chief Financial Officer | ||
| 615-771-7575 | 615-771-7575 |


Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
Starlink Plans Satellite Orbit Reconfiguration in 2026 to Boost Space Safety
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
Samsung Signals Comeback With HBM4 Chips as AI Market Heats Up
Drugmakers Plan 2026 U.S. Price Increases on Over 350 Branded Medications Despite Political Pressure
Neuralink Plans Automated Brain Implant Surgeries and Mass Production by 2026
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions 



